We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Global Asbestos Deaths Keep Rising

By HospiMedica staff writers
Posted on 01 Oct 2001
Despite increasingly strict exposure standards for asbestos, the number of asbestos-linked cancers will continue to grow because of the length of time required for them to develop, according to a symposium held at the 11th Annual Congress of the European Respiratory Society (ERS) in Berlin, Germany.

Occupational asbestos exposure in Western Europe, North America, Japan, and Australia peaked in the 1970s, but recent estimates indicate that 30,000 new asbestos-related cancers continue to be diagnosed there every year. More...
These include 10,000 cases of mesotheliomas and around 20,000 cases of lung cancer. Moreover, doctors believe there will be a steady rise in the frequency of asbestos-related cancers until at least 2010 or 2020, since they take many years to develop. As a result, for example, mesothelioma rates are expected to rise in France by as much as 25% every three years.

A study by researchers at Erasmus Hospital (Brussels, Belgium) showed that in a randomly chosen urban population, out of 160 autopsies performed between 1998 and 2000, pleural plaques were found in 14% of subjects and concentrations of more than 1,000 asbestos bodies per gram of dry lung tissue were found in 13% of subjects. In other words, almost one person in every seven subjects bore the scars of asbestos exposure.

The symposium participants agreed that they urgently needed to determine the best ways of dealing with this time bomb. "Should we then screen systemically for the signs of past exposure in all patients who have had contact with asbestos?” asked Paul De Vuyst, co-chairman of the symposium and chairman of the Occupational and Environmental Health Group of ERS. "This is the crux of the question, and there are no uniform satisfactory answers at present.” At the close of the meeting, De Vuyst called for the creation of a European task force responsible for centralizing data and defining what groups would benefit from early screening.




Related Links:
European Respiratory Society (ERS)

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Imaging Table
Stille imagiQ2
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.